(603077)"SICHUAN HEBANG BIOTECHNOLOGY CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 603077 · · 12 pages · Chinese
Summary by 6ix AI
The report includes a summary of major accounting data and financial indicators, along with changes and reasons for these changes. It also provides insights into the company's total assets and equity attributable to shareholders at the end of the reporting period. The financial statements included in the report are unaudited, and the company assures the accuracy and completeness of the information presented.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Sichuan Hebang Biotechnology Co. Ltd. on 6ix
Earlier from Sichuan Hebang Biotechnology
- (603077)"SICHUAN HEBANG BIOTECHNOLOGY CO., LTD."Announcement on Interest Payment for "HEBANG Convertible Bonds"
- (603077)"SICHUAN HEBANG BIOTECHNOLOGY CO., LTD."Announcement on Progress in Providing Guarantee
- (603077)"Sichuan Hebang Biotechnology Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Release of Pledge and Pledge of Certain Shares Held by the Controlling Shareholder
Follow Sichuan Hebang Biotechnology into a list and get an email when it puts out news.
Follow Sichuan Hebang Biotechnology